1. Home
  2. SUPN vs VECO Comparison

SUPN vs VECO Comparison

Compare SUPN & VECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • VECO
  • Stock Information
  • Founded
  • SUPN 2005
  • VECO 1945
  • Country
  • SUPN United States
  • VECO United States
  • Employees
  • SUPN N/A
  • VECO N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • VECO Industrial Machinery/Components
  • Sector
  • SUPN Health Care
  • VECO Technology
  • Exchange
  • SUPN Nasdaq
  • VECO Nasdaq
  • Market Cap
  • SUPN 1.9B
  • VECO 1.9B
  • IPO Year
  • SUPN 2012
  • VECO 1994
  • Fundamental
  • Price
  • SUPN $34.70
  • VECO $28.70
  • Analyst Decision
  • SUPN Hold
  • VECO Buy
  • Analyst Count
  • SUPN 1
  • VECO 7
  • Target Price
  • SUPN $36.00
  • VECO $45.57
  • AVG Volume (30 Days)
  • SUPN 295.5K
  • VECO 593.8K
  • Earning Date
  • SUPN 11-04-2024
  • VECO 11-06-2024
  • Dividend Yield
  • SUPN N/A
  • VECO N/A
  • EPS Growth
  • SUPN N/A
  • VECO 17.14
  • EPS
  • SUPN 0.08
  • VECO 1.44
  • Revenue
  • SUPN $630,163,000.00
  • VECO $701,653,000.00
  • Revenue This Year
  • SUPN $4.01
  • VECO $9.24
  • Revenue Next Year
  • SUPN $0.10
  • VECO $9.96
  • P/E Ratio
  • SUPN $459.76
  • VECO $20.08
  • Revenue Growth
  • SUPN N/A
  • VECO 9.49
  • 52 Week Low
  • SUPN $23.05
  • VECO $24.56
  • 52 Week High
  • SUPN $35.56
  • VECO $49.25
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 61.96
  • VECO 33.13
  • Support Level
  • SUPN $33.73
  • VECO $28.46
  • Resistance Level
  • SUPN $35.56
  • VECO $30.32
  • Average True Range (ATR)
  • SUPN 0.84
  • VECO 0.85
  • MACD
  • SUPN 0.04
  • VECO -0.10
  • Stochastic Oscillator
  • SUPN 62.45
  • VECO 8.03

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company that is principally engaged in designing, developing, and manufacturing thin-film process equipment, which is mainly used to produce electronic devices. The company's product categories by market consist of lighting, display, and power electronics; advanced packaging; MEMS and RF; scientific and industrial; and data storage. The lighting, display, and power electronics market accounts for over half of the total revenue. The company offers products and services in the United States; China; Europe, the Middle East, and Africa, or EMEA; and the rest of the world, with overseas markets contributing the majority of total revenue.

Share on Social Networks: